S1-induced vasospastic angina—diagnostic utility of Holter ECG: a report of a case

BACKGROUND: Vasospastic angina is a rare but potentially life-threatening adverse event (AE) of S1, an oral fluoropyrimidine anticancer agent. However, this AE is not well known owing to its low incidence. We report herein a case of a patient who suffered from vasospastic angina associated with S1 c...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanda, Tatsuo, Wakai, Atsuhiro, Chida, Tadasu, Nakamura, Yuichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445223/
https://www.ncbi.nlm.nih.gov/pubmed/32833093
http://dx.doi.org/10.1186/s40792-020-00975-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445223/
https://www.ncbi.nlm.nih.gov/pubmed/32833093
http://dx.doi.org/10.1186/s40792-020-00975-x

Ejemplares similares